Factors Influencing Oral Anti-diabetic Medication Adherence among Type 2 Diabetes Mellitus in Urban Health Training Centre, Bengaluru.

Lakshmi  Hulugappa; Chethana Ramegowda; Anwith Huluvadi Shivalingaiah

doi:10.55489/njcm.13062022405

Authors

Lakshmi Hulugappa Akash Institute of Medical Sciences, Bengaluru, India
Chethana Ramegowda Kempegowda Institute of Medical Sciences, Bengaluru, India
Anwith Huluvadi Shivalingaiah Kempegowda Institute of Medical Sciences, Bengaluru, India

DOI:

https://doi.org/10.55489/njcm.13062022405

Keywords:

diabetes mellitus, type 2, medication adherence, factors, oral anti-diabetic, Urban area

Abstract

Background: Medication adherence is a major challenge in treatment of type 2 diabetes. Hence the present study was undertaken to assess the factors influencing drug adherence in Type 2 diabetes Bengaluru.

Methods: A descriptive study was conducted in urban health training centre Bengaluru for a period of 9 months. A total of 70 type 2 Diabetes patients only on oral drugs willing to give informed consent were included. Institutional Ethical Committee clearance was obtained and pre-tested semi structured proforma was administered and the probable factors that affect adherence was included. Data was entered in Microsoft excel and analyzed in SPSS-21. Descriptive statistics and inferential statistics like Binary logistic regression was used to assess the factors influencing drugs.

Results: Around 92.8% consumed ≤2 drugs and consumed single or combination of drugs. Most common anti-diabetic drug consumed was Biguanides in 64(91.4%). Good adherence (0-2 score) to oral anti-diabetic drugs was observed in 43 (61%) study subjects the factor significantly associated with poor adherence in Binary Logistic Regression Model is sometimes forgetting to consume the medication.

Conclusion: The factors that influenced oral anti-diabetic drugs good adherence is consuming the medications without forgetting. Efforts are needed to improve adherence and self-management techniques to prevent complications.

References

World Health Organization. Factsheets. [Online][cited 2021 July 2 ].Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.

International Diabetes Federation. About Diabetes Atlas. [Online][cited 2021 July 1]. Available from: https://www.diabetesatlas.org/en/sections/demographic-and-geographic-outline.html

Tiv M, Viel JF, Mauny F, Eschwege E, Weill A, Fournier C et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French population-based study. PLoS ONE 2012; 7(3): e32412. Doi: https://doi.org/10.1371/journal.pone.0032412 PMid:22403654 PMCid:PMC3293796

Wibowo MINA, Yasin NM, Kristina SA, Prabandari YS. Exploring of Determinants Factors of Anti-Diabetic Medication Adherence in Several Regions of Asia - A Systematic Review. Patient Prefer Adherence. 2022;16:197-215. Doi: https://doi.org/10.2147/PPA.S347079 PMid:35115768 PMCid:PMC8803611

Shrestha SS, Shakya R, Karmacharya BM, Thapa P. Medication adherence to oral hypoglycemic agents among type II diabetic patients and their clinical outcomes with special reference to fasting blood glucose and glycosylated hemoglobin levels. Kathmandu Univ Med J 2013;43(3):226-232. Doi: https://doi.org/10.3126/kumj.v11i3.12510 PMid:24442171

Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012;35(6):1279-1284. doi: https://doi.org/10.2337/dc11-1277 PMid:22511257 PMCid:PMC3357221

Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics. 2015;33(8):811-831. doi: https://doi.org/10.1007/s40273-015-0268-9 PMid:25787932 PMCid:PMC4519633

Faria GHT, Zanetti ML, Haas VJ. Factors related to patient adherence to antidiabetic drug therapy. Rev Latinoam Enfermagem 2009 janeiro-fevereiro; 17(1):46-51. Doi: https://doi.org/10.1590/S0104-11692009000100008 PMid:19377806

Fadare J, Olamoyegan, M,Gbadegesan BA. Medication adherence and direct treatment cost among diabetes patients attending a ter-tiary healthcare facility in Ogbomosho, Nigeria. Malawi Medical Journal; 27 (2): 65-70 June 2015. Doi: https://doi.org/10.4314/mmj.v27i2.7 PMid:26405515 PMCid:PMC4562083

Pal R, Pal S, Barua A, Ghosh MK. Health education intervention on diabetes in Sikkim. Indian J Endocr Metab. 2010; 14(1):3-7.

Medi RK, Mateti UV, Kanduri KR, Konda SS. Medication adherence and determinants of non-adherence among south Indian diabetes patients. J Soc Health Diabetes. 2015;3:48-51. Doi: https://doi.org/10.4103/2321-0656.140892

Kazniski J, Glowacka A, Drzewoski J. Type 2 diabetic patients compliance with drug therapy and glycaemic control. Diabetologia. 2007; 7(4):199-203.

Sweileh WM, Zyoud SH, AbuNab'a RJ, Deleq MI, Enaia MI, Nassar SM et al. Influence of patients' disease knowledge and beliefs about medicines on medication. adherence: findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Pales-tine. Biomed central public health. 2014;14:94. Doi: https://doi.org/10.1186/1471-2458-14-163

Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self-management practices among type-2 diabetics in Ethiopia. N Am J Med Sci 2011;3:418-23. Doi: https://doi.org/10.4297/najms.2011.3418 PMid:22362451 PMCid:PMC3271397

Anurupa MS, Aditya A, Angadi N. A Study of Medication Adherence and Self-Care Practices among Type- 2 Diabetes Patients in Da-vangere. Natl J Community Med 2019;10(1):12-16.

Arulmozhi S, Mahalakshmy T. Self care and medication adherence among type 2 diabetics in Puducherry, Southern India: a hospital based study. J Clin Diag Res.2014; 8(4):01-03.

Faria GHT, Zanetti ML, Santos MA, Teixeira CRS. Patients' knowledge regarding medication therapy to treat diabetes: a challenge for health care services. Acta Paul Enferm. 2009;22(5):612-7. Doi: https://doi.org/10.1590/S0103-21002009000500003

Banu S, Prasanth YM, Anjana K. Adherence to treatment among type 2 diabetes mellitus patients visiting a tertiary care hospital in Mangalore. IJBR. 2014; 5(4):254-256. Doi: https://doi.org/10.7439/ijbr.v5i4.582

Lawton J, Peel E, Parry O, Douglas M. Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. Diabet Med 2008; 25: 491-495. Doi: https://doi.org/10.1111/j.1464-5491.2008.02400.x PMid:18294222

Koprulu F, Bader JK, Hassan AGM, Abduelkarem AR, Mahmood DA. Evaluation of adherence to diabetic treatment in Northern re-gion of United Arab Emirates. Trop J Res. 2014; 13(6):989-995. Doi: https://doi.org/10.4314/tjpr.v13i6.24